Tissue factor: A mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis

Journal of Experimental Medicine

Volumn 204, Issue 7, 2007, Pages 1595-1601

  Anthoni, Christoph ^a,b   Russell, Janice ^a   Wood, Katherine C ^a   Stokes, Karen Y ^a   Vowinkel, Thorsten ^b   Kirchhofer, Daniel ^c   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCX 3607; DEXTRAN; DYE; SODIUM SULFATE; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TISSUE FACTOR ANTIBODY; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CREMASTER MUSCLE; DISEASE ACTIVITY; DISEASE MODEL; ENTERITIS; EXPERIMENTAL STUDY; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE ADHERENCE; LIGHT; MALE; MEDIATOR RELEASE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; THROMBOCYTE ADHESION; THROMBOGENESIS; TISSUE INJURY; VENULE;

ANIMALS; ANTITHROMBINS; BLOOD COAGULATION; BLOOD PLATELETS; COLITIS; COLON; DISEASE MODELS, ANIMAL; INFLAMMATION; LEUKOCYTES; MICE; MICROCIRCULATION; THROMBOPLASTIN; THROMBOSIS;

EID: 34447263762     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20062354     Document Type: Article

References (43)

1. Irving, P.M., K.J. Pasi, and D.S. Rampton. 2005. Thrombosis and inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 3:617-628.
2. Twig, G., G. Zandman-Goddard, M. Szyper-Kravitz, and Y. Shoenfeld. 2005. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Ann. NY Acad. Sci. 1051:166-173.
3. Hatoum, O.A., H. Miura, and D.G. Binion. 2003. The vascular contribution in the pathogenesis of inflammatory bowel disease. Am. J. Physiol. Heart Circ. Physiol. 285:H1791-H1796.
4. Chamouard, P., L. Grunebaum, M.L. Wiesel, P.L. Frey, C. Wittersheim, R. Sapin, R. Baumann, and J.P. Cazenave. 1995. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Eur. J. Gastroenterol. Hepatol. 7:1183-1188.
5. Esmon, C.T. 2004. The impact of the inflammatory response on coagulation. Thromb. Res. 114:321-327.
6. Esmon, C.T. 2005. The interactions between inflammation and coagulation. Br. J. Haematol. 131:417-430.
7. Solem, C.A., E.V. Loftus, W.J. Tremaine, and W.J. Sandborn. 2004. Venous thromboembolism in inflammatory bowel disease. Am. J. Gastroenterol. 99:97-101.
8. van Bodegraven, A.A. 2003. Haemostasis in inflammatory bowel diseases: clinical relevance. Scand. J. Gastroenterol. Suppl. 239:51-62.
9. Camerer, E., W. Huang, and S.R. Coughlin. 2000. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. USA. 97:5255-5260.
10. Coughlin, S.R. 2005. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3:1800-1814.
11. Cunningham, M.A., E. Rondeau, X. Chen, S.R. Coughlin, S.R. Holdsworth, and P.G. Tipping. 2000. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J. Exp. Med. 191:455-462.
12. Major, C.D., R.J. Santulli, C.K. Derian, and P. Andrade-Gordon. 2003. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 23:931-939.
13. Fan, Y., W. Zhang, and M. Mulholland. 2005. Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells. J. Surg. Res. 129:196-201.
14. Li, T., H. Wang, and S. He. 2006. Induction of interleukin-6 release from monocytes by serine proteinases and its potential mechanisms. Scand. J. Immunol. 64:10-16.
15. Lindner, J.R., M.L. Kahn, S.R. Coughlin, G.R. Sambrano, E. Schauble, D. Bernstein, D. Foy, A. Hafezi-Moghadam, and K. Ley. 2000. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J. Immunol. 165:6504-6510.
16. Vergnolle, N., L. Cellars, A. Mencarelli, G. Rizzo, S. Swaminathan, P. Beck, M. Steinhoff, P. Andrade-Gordon, N.W. Bunnett, M.D. Hollenberg, et al. 2004. A role for proteinase-activated receptor-1 in inflammatory bowel diseases. J. Clin. Invest. 114:1444-1456.
17. Sharma, L., E. Melis, M.J. Hickey, C.D. Clyne, J. Erlich, L.M. Khachigian, P. Davenport, E. Morand, P. Carmeliet, and P.G. Tipping. 2004. The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia. Am. J. Pathol. 165:331-340.
18. Arnold, C.S., C. Parker, R. Upshaw, H. Prydz, P. Chand, P. Kotian, S. Bantia, and Y.S. Babu. 2006. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor. Thromb. Res. 117:343-349.
19. Rumbaut, R.E., R.V. Bellera, J.K. Randhawa, C.N. Shrimpton, S.K. Dasgupta, J.F. Dong, and A.R. Burns. 2006. Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil- independent mechanism. Am. J. Physiol. Heart Circ. Physiol. 290:H1671-H1679.
20. Vowinkel, T., T.J. Kalogeris, M. Mori, C.F. Krieglstein, and D.N. Granger. 2004. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig. Dis. Sci. 49:556-564.
21. Pawlinski, R., B. Pedersen, G. Schabbauer, M. Tencati, T. Holscher, W. Boisvert, P. Andrade-Gordon, R.D. Frank, and N. Mackman. 2004. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood. 103:1342-1347.
22. Pawlinski, R., and N. Mackman. 2004. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit. Care Med. 32:S293-S297.
23. Osterud, B., and E. Bjorklid. 2006. Sources of tissue factor. Semin. Thromb. Hemost. 32:11-23.
24. Mackman, N. 2006. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol. Dis. 36:104-107.
25. Reinhardt, C. 2007. New locations of intravascular tissue factor: indications. Hamostaseologie. 27:55-58.
26. Ritis, K., M. Doumas, D. Mastellos, A. Micheli, S. Giaglis, P. Magotti, S. Rafail, G. Kartalis, P. Sideras, and J.D. Lambris. 2006. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J. Immunol. 177:4794-4802.
27. Schoenmakers, S.H., A.P. Groot, S. Florquin, P.H. Reitsma, and C.A. Spek. 2004. Blood cell-derived tissue factor influences host response during murine endotoxemia. Blood Cells Mol. Dis. 32:325-333.
28. Sevastos, J., S.E. Kennedy, D.R. Davis, M. Sam, P.W. Peake, J.A. Charlesworth, N. Mackman, and J.H. Erlich. 2007. Tissue factor deficiency and PAR-1 deficiency are protective against renal ischaemia reperfusion injury. Blood. 109:577-583.
29. Rumbaut, R.E., J.K. Randhawa, C.W. Smith, and A.R. Burns. 2004. Mouse cremaster venules are predisposed to light/dye-induced thrombosis independent of wall shear rate, CD18, ICAM-1, or P-selectin. Microcirculation. 11:239-247.
30. Rumbaut, R.E., D.W. Slaff, and A.R. Burns. 2005. Microvascular thrombosis models in venules and arterioles in vivo. Microcirculation. 12:259-274.
31. Danese, S., A. Papa, S. Saibeni, A. Repici, A. Malesci, and M. Vecchi. 2007. Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Am. J. Gastroenterol. 102:174-186.
32. Wan, M.X., Q. Liu, Y. Wang, and H. Thorlacius. 2002. Protective effect of low molecular weight heparin on experimental colitis: role of neutrophil recruitment and TNF-alpha production. Inflamm. Res. 51:182-187.
33. Fries, W., E. Pagiaro, E. Canova, P. Carraro, G. Gasparini, F. Pomerri, A. Martin, C. Carlotto, E. Mazzon, G.C. Sturniolo, and G. Longo. 1998. The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat. Aliment. Pharmacol. Ther. 12:229-236.
34. Vowinkel, T., C. Anthoni, K.C. Wood, K.Y. Stokes, J. Russell, L. Gray, S. Bharwani, N. Senninger, J.S. Alexander, C.F. Krieglstein, et al. 2007. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon. Gastroenterology. 132:955-965.
35. Okayasu, I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98:694-702.
36. Ebaugh, F.G., Jr., and W.L. Beeken. 1959. Quantitative measurement of gastrointestinal blood loss. II. Determination of 24-hour fecal blood loss by a chemical photospectrometric technique. J. Lab. Clin. Med. 53:777-788.
37. Cooper, H.S., S.N. Murthy, R.S. Shah, and D.J. Sedergran. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69:238-249.
38. Dieleman, L.A., M.J. Palmen, H. Akol, E. Bloemena, A.S. Pena, S.G. Meuwissen, and E.P. Van Rees. 1998. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 114:385-391.
39. Cooper, D., K.D. Chitman, M.C. Williams, and D.N. Granger. 2003. Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G1027-G1033.
40. Mori, M., J.W. Salter, T. Vowinkel, C.F. Krieglstein, K.Y. Stokes, and D.N. Granger. 2005. Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules. Am. J. Physiol. Gastrointest. Liver Physiol. 288:G920-G926.
41. Pamuk, G.E., O. Vural, B. Turgut, M. Demir, H. Umit, and A. Tezel. 2006. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am. J. Hematol. 81:753-759.
42. Stokes, K.Y., E.C. Clanton, K.P. Clements, and D.N. Granger. 2003. Role of interferon-gamma in hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation. 107:2140-2145.
43. Kirchhofer, D., P. Moran, S. Bullens, F. Peale, and S. Bunting. 2005. A monoclonal antibody that inhibits mouse tissue factor function. J. Thromb. Haemost. 3:1098-1099.